Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience
Titel:
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience
Auteur:
Fine, Robert L. Gulati, Anthony P. Krantz, Benjamin A. Moss, Rebecca A. Schreibman, Stephen Tsushima, Dawn A. Mowatt, Kelley B. Dinnen, Richard D. Mao, Yuehua Stevens, Peter D. Schrope, Beth Allendorf, John Lee, James A. Sherman, William H. Chabot, John A.